Prevalence of intestinal parasites among HIV/AIDS patients attending Infectious Disease Hospital Kano, Nigeria
Ebenezer Feyisayo Jegede, Esther Tinuade Ibijoke Oyeyi, ArmaYau Hamisu Bichi, Henry Akwen Mbah, Kwasi Torpey
The Pan African Medical Journal. 2014;17:295. doi:10.11604/pamj.2014.17.295.3707

Create an account  |  Sign in
EPI Helina 2017
"Better health through knowledge sharing and information dissemination "

Research

Prevalence of intestinal parasites among HIV/AIDS patients attending Infectious Disease Hospital Kano, Nigeria

Cite this: The Pan African Medical Journal. 2014;17:295. doi:10.11604/pamj.2014.17.295.3707

Received: 11/12/2013 - Accepted: 28/03/2014 - Published: 18/04/2014

Key words: HIV/AIDS, CD4+ count, intestinal parasites

© Ebenezer Feyisayo Jegede et al. The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Available online at: http://www.panafrican-med-journal.com/content/article/17/295/full

Corresponding author: Dr. Henry Akwen Mbah, FHI-360 Plot 1073-A1 J. S Tarka Street, GODAB Plaza, Area 3 Garki-Abuja, Nigeria (hmbah@ng.fhi360.org)


Prevalence of intestinal parasites among HIV/AIDS patients attending Infectious Disease Hospital Kano, Nigeria

 

Ebenezer Feyisayo Jegede1, Esther Tinuade Ibijoke Oyeyi2, ArmaYau Hamisu Bichi2, Henry Akwen Mbah1,&, Kwasi Torpey1

 

1Family Health International (FHI 360), Nigeria, 2Department of Zoology, Faculty of Science, Bayero University Kano, Nigeria

 

 

&Corresponding author
Dr. Henry Akwen Mbah, FHI-360 Plot 1073-A1 J. S Tarka Street, GODAB Plaza, Area 3 Garki-Abuja, Nigeria

 

 

Abstract

Introduction: Intestinal parasitic infection has been a major source of morbidity in tropical countries especially among HIV patients. The aim of this study was to determine prevalence of intestinal parasites and its association with immunological status and risk factors among HIV infected patients in Kano, Nigeria.

 

Methods: 105 HIV+ subjects and 50 HIV- controls were recruited into the studies from June to December 2010. Clinical information was collected using a questionnaire. Single stool and venous blood samples were collected from each subject. Stool examination and CD4+ count were performed.

 

Results: Prevalence of intestinal parasites was 11.4% and 6% among the HIV+ and control subjects respectively with no statistically significant difference (p=0.389). Specifically, the following intestinal parasites were isolated from HIV+ subjects: Entamoebahistolytica (5.7%), hookworm (3.8%), Entamoeba coli (1%), Blastocystishominis (1%). Only Entamoebahistolytica was isolated among the control subjects. The mean CD4+ count of HIV+ and control subjects was 287 cells/ul and 691 cells/µlrespectively while the median was 279(Q1-120, Q3-384) cell/µl and 691(Q1-466, Q3-852) cell/µlrespectively with statistically significant difference (P= 0.021).Diarrhea and the absence of anti-parasitic therapy seem to be important risk factors associated with the occurrence of intestinal parasites among HIV+ subjects. A higher prevalence (14.5%) of intestinal parasites was observed in subject with CD4+ count <350cell/µl compared to (4%) prevalence in those with CD4+ count >350cell/µl.

 

Conclusion: Routine examination for intestinal parasites should be carried out for better management of HIV/AIDS patients.

 

 

Introduction

According to UNAID and WHO joint report, an estimated 35.3 million people were living with HIV globally at the end of 2012 with 69% of these persons living in Sub-Saharan Africa[1]. Opportunistic infection poses major health problems among HIV patients particularly in the late stage of the disease when immune- suppression is severe.

 

Intestinal parasitic infection has been a major source of morbidity in tropical countries especially among HIV patients[2–5]. Diarrhea due to intestinal microbial infections is a frequent manifestation among HIV infected patients. It has been speculated that HIV infected patients may have unique types of intestinal infections, and that activation from such parasites may affect the progression of HIV disease[6].

 

Initiating treatment and laboratory monitoring of HIV/AIDs patients involve series of laboratory investigations, such as CD4 count, hematology and biochemistry. However, in Antiretroviral Treatment (ART) programs information on the intestinal parasitic status of HIV patients is not readily available despite its clinical importance.

 

There are some reports on the distribution of intestinal parasites among different communities in Nigeria[2,7,8].Unfortunately, there is inadequate information on the prevalence of intestinal parasitic infection among HIV/AIDS patients,although improved diagnosis techniques to indentify opportunistic intestinal parasites are readily available in Nigeria. This study sought to determine the prevalence of intestinal parasitic infection among HIV/AIDS patients at Infectious Disease Hospital, (IDH) Kano.It also examined their immune status and some predisposing factors of acquiring intestinal parasites.

 

 

Methods

Study population, design and sample size

 

Infectious Disease Hospital, Kano, a 250-bed hospital, located in SabonGari Kano in the North West region of Nigeria. IDH Kano is a comprehensive ART site since 2005. Presently, about 12,000 patients are enrolled in IDH Kano for ART. Sample collection and clinical –epidemiologic questionnaire were performed between June 2010 and December 2010.

 

This was a cross sectional comparative study.Random sampling technique was used to select 105 consenting HIV positive subjects. The selection of participants was based at interval of three for each consenting participants. The sample size required for this study was calculated using the formula N=z2Pq/d2 as previously described [9]based on a prevalence of 7.29% for intestinal parasites in Kano[10].

 

Where:

 

N = number of samples
Z = Confidence interval – 95% = 1.96
Kano prevalence of similar study was 7.29% [10]
P = Kano state HIV prevalence rate, q = (1-p)
d= Allowable error taken to be 5% (0.05).
N = (1.96)2 x 0.0729 x (1-0.0729)/ (0.05)2
= 3.8416 x0.0729 (0.9271)/ (0.05)2
= 103.85

 

Thus, a minimum sample size of 103.85 was required for the study. Only 50 controls ware recruited through consecutive sampling of consenting HIV negative subjects at the HIV Testing and counselling (HTC) unit. Each study participant responded to a questionnaire on medical history, sexual behavior and basic socio-economic characteristics.

 

Specimen collection and analysis

 

Stool for intestinal parasites: Single stool sampleswere collected from each participant intosterile wide mouth screw cap labeled containers and analyzed within 24 hours of collection. They were analyzed by direct wet mount[11], formal-ether concentrated method and modified ZiehlNeelsen staining[12]to detect cysts, oocyst, ova, larvae andtrophozoites of parasites.

 

Blood for CD4 count: Five milliliters of venous blood samples were aseptically drawn into labeled EDTA tubes and mixed properly to avoid blood clots. CD4 count was done within six hours of sample collection by flow cytometry method using PARTEC Cyflow[13].

 

Data Analysis: Data generated was entered into Microsoft excel 2007 cleaned and imported into Statistical Package for Social Science (SPSS) software version 16 for analysis. Differences in proportions of HIV positive patients with CD4 values within specific ranges and stool examination results showing characteristic findings was tested using chi-square test. A <0.05 probability will be considered statistically significant. Logistics regression models to evaluate the effect of age, sex, occupation, educational status, source of drinking water, type of toilet facility used, contact with pets, and CD4 values on specific stool characteristics was fitted.

 

Ethical Approval: Ethical approval was given by Kano State Hospitals Management Board in Nigeriaand Family Health International’s Office of International Research Ethics in North Carolina, USA.

 

 

Results

Basic characteristics of studied population

 

A total of 105 HIV positive subjects (57 female and 48 male) with a mean age of 34.4 years and 50 HIV negative subjects (15 females and 35 males) with a mean age 31.2 years as control were evaluated in this study (Table 1). More than 80% in both groups were Hausa by tribe. The majority (61.9%) of the HIV positive subjects had no formal education compared to only 20% in the control group. Similarly, a greater proportion (57%) of the HIV positive subjects were unemployed compared to (14%) in the control group.

 

Prevalence of intestinal parasite

 

The overall prevalence of intestinal parasites was 11.4% in HIV positive subjects, which did not present significant difference when compared to (6%) HIV negative controls (Table 2). Four different species of intestinal parasites arranged in order of prevalence, Entamoebahistolytica (5.7%),Ancylostomaduodenale (3.8%), Entamoeba coli (1%) and Blastocystishominis (1%) were recovered from the HIV positive subjects. Only one species, Entamoebahistolytica (6%) was found among the control group.

 

In both groups, the prevalence was higher in females than males. Among HIV positive subjects it was 14% in females and 8% in males. For the control group it was 6.7% in females and 5.7% in males. Concerning immune status of subjects the mean CD4+count among HIV positive subjects was 287cell/µl (range 12-1067) cell/µl, while control group presented 691cell /µl ( range 134-1409) cell/µl with a statistical significant difference between the two groups (P=0.021). The median and interquartile range of CD4+ count among both groups was 279cell/µl (Q1- 120,Q3- 384 ) for HIV infected while 691cell/µl (Q1-466, Q3-852) was recorded among HIV negative control group.A higher percentage (72.3%) of the HIV positive subjects had a CD4+ cell count below the 350 cell/µl threshold recommended by WHO for ART initiation in developing countries. With only one exception, all cases of parasitic infection were found among HIV positive subjects with CD4+ count lower than 350cell/µl,although regression analysis did not show a significant association (Table 2).

 

The risk factors associated with transmission of intestinal parasitic infection in HIV infected subjects is presented in Table 2. The prevalence was lower (8.2%) among HIV infected subjects on ART compared to those not on treatment (16%). The prevalence ofintestinal parasites was lower (9.2%) among HIV infected subjects on anti-parasitic therapy compared to those not on anti-parasitic therapy (43%), which was significantly associated to acquiringintestinalparasitic infection showed by regression analysis (Table 2) The prevalence of intestinal parasitic infection was higher (45%) in HIV infected subjects presenting with diarrhea compared to those without this symptoms (3.5%). Regression analysis also showed diarrhea to be a predictor of intestinal parasites amongHIV patients.The prevalence was about 13% when the toilet type used was either open field or public toilet and zero among in-house toilet users.

 

Based on the source of drinking water, the prevalence among consumers of tap water was (13.2%), well water was (11.6%), but was absent among tank water consumers. The assessment of contact with pets/animals revealed similar prevalence rates (10% and 12%) among the contact and non- contact groups respectively.

 

An incidental finding, following stool examination, was the presence of numerous pus cells among 7.6% of the HIV positive patients with CD4+ count as low as 29 cell/µl. Pus cells were absent in the stool of HIV negative control individuals .

 

 

Discussion

In this study, we investigated the prevalence of intestinal parasitic infection among HIV seropositive individuals and its association withimmune status in IDH Kano Nigeria. This study detected non-opportunistic intestinal parasites in 11.4% of HIV positive study participants. The prevalence was lower (6.0%) among HIV negative control subjects. Four different speciesnamely, Entamoebahistolytica (5.7%), Ancylostomaduodenale (3.8%) Blastocystishominis (1%) Entamoeba coli (1%) were isolated from the HIV positive subjects.It is noteworthy that among the 20 HIV positive subjects presenting with diarrhea, the prevalence of non-opportunistic intestinal parasites was 45%. Thus, clinical diarrhea seems to be strongly associated with presence of intestinal parasites among these subjects.

 

We observed numerous pus cells in the stool of highly immune-compromised HIV positive subjects. Further microbiological investigations would be required to identify the specific pathogens triggering this reaction and the relationship with HIV/AIDS, immune status and diarrhea.

 

Based on the method used for parasite concentration and detection in this study, the intestinal parasites burden may have been underestimated. Probably because, other diagnostic techniques for specific parasites concentration and identification such Kato- katz, Bearman’s method, floatation technique and microsporidium spore staining were not used. The prevalence of parasitic infection (11.4%), reported among HIV infected patients in this study was lower than that found in similar studies in Nigeria reporting a prevalence above 24% [2,8,14].

 

The absence of opportunistic intestinal parasites in this study is similar to the prevalence reportedin other studies among HIV positive patients in Lagos [15] and Enugu [16] in Nigeria. Converselya prevalence rate of about 25% for Cryptosporidium species was reported in Jos [7] and Abeokuta [17] in Nigeria. Higher prevalence (31.4%) of opportunistic intestinal parasites were found among HIV patients suffering from diarrhea in Korea [18]. One of the possible reason for this variation could be that majority (71%) of HIV infected patients did not have contact with pets or other animals which are potential sources of transmission of oocyst of coccidians parasites .Another reason could be thatthe study participants are enrolled into the ART program, managed and monitored by trained ART physicians, and placed on Cotrimoxazole therapy according to the national guidelines [19].

 

In our study, intestinal protozoan pathogens were detected more frequently in cases with CD4+ count <200/cell/µl among HIV/AIDS patients as in other studies [20,21].In this study, we found Entamoebahistolytica (5.7%) to be the most prevalent parasite in HIV positive subjects. This is in conformity with previous studies done in Abuja byUdeh et al[14] where the highest prevalence obtained for this parasite was 36.79%. In contrast, Cryptosporidium parvum has been reportedas the most common parasite in HIV infected persons [8]. Previous studies conducted in Nepal[22] and Iran [23] reported Crytosopridiumparvum and Giardia lambliaas commonest parasites among HIV infected persons and most of the times were associated with diarrhea. In this study, it was observed that females had higher prevalence (14%) of intestinal parasitic infection than males (8.3%) among HIV positive subjects with no significant difference (P > 0.05). This is consistent with a report from Abeokuta, Nigeria [2].Diarrhea and absence of anti-parasitic therapy are the most likely factors for predicting the acquiring of common intestinal parasites among HIV infected patients.

 

Diarrhea is a common symptom in HIV infectionand a major signs to AIDS progression with possibility of various opportunistic infections, however, none of the opportunistic coccidian was identified in this study. Nevertheless this fact is in conflicts with other reports in Nigeria [7,8].

 

The study had some potential limitations. The control group does not match the cases, as it was difficult to recruit apparently healthy persons in this hospital setting. In addition, stool examination was done only once, which may not have given an accurate picture of intestinal parasite prevalence.

 

 

Conclusion

In conclusion, Entamoebahistolytica, Ancylostomaduodenale and Blastocystishominis are the most common intestinal pathogens among HIV infected patients in IDH Kano. Diarrhea and absence of anti-parasitic therapy are the most likely factors for predicting the acquiring of common intestinal parasites among HIV infected patients, These findings add conceptual importance and relevance to the association between intestinal parasites and HIV infection. Thus routine stool examination should be considered as an important component in ART monitoring program in Nigeria.

 

 

Competing interests

The Authors declare that they have no financial or personal relationship(s) which may have inappropriately motivate them in the writing of this paper.

 

 

Authors’ contributions

All authors have contributed to the study in ways that conform to the ICMJE authorship criteria. All the authors have read and approved the final version of the manuscript

 

 

Acknowledgments

The Authors wish to acknowledge the contribution of Kano State Hospitals Management Board for the approval of the research protocol and IDH Kano laboratory staff for support in administration of questionnaire and sample collection. FHI-360 support to IDH Kano for ART through the GHAIN project and FHI staff time is highly acknowledged. Finally, we will like to appreciate Dr. OlukoladeShobo who assisted with the statistical analysis. The opinions expressed herein are those of the authors and do not necessarily reflect the views of FHI-360.

 

 

Tables

Table 1: Baseline characteristics of studied population

Table 2: Prevalence of intestinal parasites and risk factorsanalysis among HIV patients

 

 

References

  1. UNAID. UNAIDS report on the global AIDS epidemic. 2013. Geneva: Switzerland. UNAID. PubMed | Google Scholar

  2. Okodua M, Adeyeba OA, Tatfeng YM, Okpala H. Age and Sex Distribution of Intestinal Parasitic Infection Among HIV Infected Subjects in Abeokuta, Nigeria. Online J Heal Allied Sci. 2003;2(4):1–5. PubMed | Google Scholar

  3. Lockwood DN, Weber JN. Parasite infections in AIDS. Parasitol Today Pers ed. 1989;5(10):310–6. PubMed | Google Scholar

  4. Goodgame RW. Understanding intestinal spore-forming protozoa: cryptosporidia, microsporidia, isospora, and cyclospora. Ann Intern Med. 1996;124(4):429–41. PubMed | Google Scholar

  5. Kaplan JE, Hu DJ, Holmes KK, Jaffe HW, Masur H, De Cock KM. Preventing opportunistic infections in human immunodeficiency virus-infected persons: implications for the developing world. Am J Trop Med Hyg. 1996;55(1):1–11. PubMed | Google Scholar

  6. Feitosa G, Bandeira AC, Sampaio DP, Badaró R, Brites C. High prevalence of giardiasis and stronglyloidiasis among HIV-infected patients in Bahia, Brazil. Brazilian J Infect Dis an Off Publ Brazilian Soc Infect Dis. 2001;5(6):339–44. PubMed | Google Scholar

  7. Ikeh EI, Obadofin MO, Brindeiro B, Baugherb C, Frost F, Vanderjagt D, et al. Intestinal parasitism in Magama Gumau rural village and Jos township in north central Nigeria. Niger Postgrad Med J. 2007;14(4):290–5. PubMed | Google Scholar

  8. Adesiji YO, Lawal RO, Taiwo SS, Fayemiwo SA, Adegboyega O. Crytosporidiosis in HIV Infected Patients with Diarrhoea in Osun State Southern Nigeria. Eur J Gen Med. 2007;4(3):119–22. PubMed | Google Scholar

  9. Wayne DW. A Foundation for Analysis in the Health Sciences. 17th ed. Wolfson, JS Richter, JM Waldron, MA Weber, DJ. 2007.

  10. Omalu I, D Duhlinska, G Anyanwu, V Pam PI. Seroprevalence of Microsporidiosis in Immunocompromised Patients in Kano-Nigeria. Internet J Parasit. 2006; 1(2). PubMed | Google Scholar

  11. Cheesbrough M. District laboratory practice in tropical countries. 2nd ed Dist Lab Pract. 2006. United Kingdom. Trop Ctries Part 2 Cambridge University Press.

  12. World Health Organization. Guidelines on standard operating procedures for laboratory Diagnosis of HIV-opportunistic infection. 2001. Geneva. WHO.

  13. Partec Cyflow. Count of CD+4 cell with cyflow counter and partec CD+4 count essay count kit. Application note on procedures partec code number 05-8401 partec GmbH Germany. 2007.

  14. Udeh EO, Goselle ON, Popova D, Abelau M, Popov TV, Jean N DJ. The prevalence of intestinal protozoans in HIV/AIDS patients in Abuja, Nigeria. Sci World J. 2008;3(3):1–4. PubMed | Google Scholar

  15. Oyerinde JP, Odugbemi T, Benson RI, Alonge AA RJ. Investigation of Cryptosporiodium in Relation to other Intestinal Parasites at the Lagos University Teaching Hospital, Lagos. West Afr J Med. 1989;8(4):264–9. PubMed | Google Scholar

  16. Nwokediuko SC, Bojuwoye BJ, Onyenekwe B. Apparent rarity of cryptosporidiosis in human immunodeficiency virus (HIV)-related diarrhoea in Enugu, South-Eastern, Nigeria. Niger Postgrad Med J. 2002;9(2):70–3. PubMed | Google Scholar

  17. Okafor JI, Okunji PO. Cryptosporidiosis in patients with diarrhoea in five hospitals in Nigeria. J Commun Dis. 1994;26(2):75–81. PubMed | Google Scholar

  18. Guk S-M, Seo M, Park Y-K, Oh M-D, Choe K-W, Kim J-L, et al. Parasitic infections in HIV-infected patients who visited Seoul National University Hospital during the period 1995-2003. Korean J Parasitol. 2005;43(1):1–5. PubMed | Google Scholar

  19. Federal Ministry of Health, Nigeria. National guidelines for HIV/AIDS treatment and care in adolescence and adults. 2010. Nigeria. Federal Ministry of Health.

  20. Kurniawan A, Karyadi T, Dwintasari SW, Sari IP, Yunihastuti E, Djauzi S, et al. Intestinal parasitic infections in HIV/AIDS patients presenting with diarrhoea in Jakarta, Indonesia. Trans R Soc Trop Med Hyg. 2009;103(9):892–8. PubMed | Google Scholar

  21. Vyas N, Aziz A, Nazneen N. Enteric pathogens in HIV-positive patients with diarrhoea and their correlation with CD4+ T-lymphocyte counts. Trop Parasitol. 2012;2(1):29–34. PubMed | Google Scholar

  22. Sapkota, D. Ghimira, P. Manandhars S. Enteric Parasitosis in Patients with Human Immunodeficiency Virus ( HIV ) Infection and Acquired Immunodeficiency Syndrome ( AIDS ) in Nepal. J Nepal Health Res Counc. 2004;2(1):1–6. PubMed | Google Scholar

  23. Zali MR, Mehr AJ, Rezaian M, Meamar AR, Vaziri S, Mohraz M. Prevalence of intestinal parasitic pathogens among HIV-positive individuals in Iran. Jpn J Infect Dis. 2004;57(6):268–70. PubMed | Google Scholar

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 


The Pan African Medical Journal articles are archived on Pubmed Central. Access PAMJ archives on PMC here

Volume 26 (Jan - Apr 2017)

Article tools

Rate this article

Altmetric

PAMJ is a member of the Committee on Publication Ethics

PAMJ is published in collaboration with the African Field Epidemiology Network (AFENET)
Currently tracked by: DOAJ, AIM, Google Scholar, AJOL, EBSCO, Scopus, Embase, IC, HINARI, Global Health, PubMed Central, PubMed/Medline, Ulrichsweb, More to come . Member of COPE.

ISSN: 1937-8688. © 2017 - Pan African Medical Journal. All rights reserved